Clinical Trials

Current Studies

A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPCA

Primary Objectives Phase II To assess the efficacy of concurrent definitive therapy followed by nivolumab compared with concurrent definitive therapy followed by observation in terms of progression-free survival (PFS). Phase III To assess the efficacy of concurrent definitive therapy followed by...

Current Studies

EF-32: Pivotal, Randomized, open-label study of Tumor Treating Fields (Optune�, 200kHz) concomitant with radiation therapy and temozolomide for the treatment of newly diagnosed glioblastoma